Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 1.88
STAA's Cash-to-Debt is ranked higher than
54% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. STAA: 1.88 )
Ranked among companies with meaningful Cash-to-Debt only.
STAA' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 2.02 Max: N/A
Current: 1.88
Equity-to-Asset 0.57
STAA's Equity-to-Asset is ranked higher than
50% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.58 vs. STAA: 0.57 )
Ranked among companies with meaningful Equity-to-Asset only.
STAA' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.6  Med: 0.65 Max: 0.81
Current: 0.57
-0.6
0.81
Piotroski F-Score: 4
Altman Z-Score: 6.32
Beneish M-Score: -3.34
WACC vs ROIC
13.46%
-19.68%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating Margin % -5.62
STAA's Operating Margin % is ranked lower than
73% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.86 vs. STAA: -5.62 )
Ranked among companies with meaningful Operating Margin % only.
STAA' s Operating Margin % Range Over the Past 10 Years
Min: -27.22  Med: -8.24 Max: 4.43
Current: -5.62
-27.22
4.43
Net Margin % -7.53
STAA's Net Margin % is ranked lower than
72% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.79 vs. STAA: -7.53 )
Ranked among companies with meaningful Net Margin % only.
STAA' s Net Margin % Range Over the Past 10 Years
Min: -30.97  Med: -9.83 Max: 2.15
Current: -7.53
-30.97
2.15
ROE % -16.65
STAA's ROE % is ranked lower than
76% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.30 vs. STAA: -16.65 )
Ranked among companies with meaningful ROE % only.
STAA' s ROE % Range Over the Past 10 Years
Min: -88.78  Med: -19.65 Max: 5.2
Current: -16.65
-88.78
5.2
ROA % -9.70
STAA's ROA % is ranked lower than
74% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.23 vs. STAA: -9.70 )
Ranked among companies with meaningful ROA % only.
STAA' s ROA % Range Over the Past 10 Years
Min: -43.45  Med: -10.93 Max: 3.01
Current: -9.7
-43.45
3.01
ROC (Joel Greenblatt) % -14.78
STAA's ROC (Joel Greenblatt) % is ranked lower than
72% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.88 vs. STAA: -14.78 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
STAA' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -131.74  Med: -21.58 Max: 22.07
Current: -14.78
-131.74
22.07
3-Year Revenue Growth Rate 3.00
STAA's 3-Year Revenue Growth Rate is ranked lower than
54% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. STAA: 3.00 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
STAA' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -40.8  Med: 3.35 Max: 63.1
Current: 3
-40.8
63.1
GuruFocus has detected 1 Warning Sign with Staar Surgical Co $STAA.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» STAA's 30-Y Financials

Financials (Next Earnings Date: 2017-08-03 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

STAA Guru Trades in Q2 2016

Jim Simons 162,700 sh (+8.18%)
» More
Q3 2016

STAA Guru Trades in Q3 2016

Jim Simons 128,200 sh (-21.20%)
» More
Q4 2016

STAA Guru Trades in Q4 2016

Jim Simons 121,700 sh (-5.07%)
» More
Q1 2017

STAA Guru Trades in Q1 2017

Jim Simons 144,300 sh (+18.57%)
» More
» Details

Insider Trades

Latest Guru Trades with STAA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339115    SIC: 3851
Compare:NAS:ATRS, NAS:PLSE, NAS:ELGX, AMEX:CRHM, OTCPK:GMDTF, NAS:ENTL, NAS:MLAB, NAS:UTMD, NAS:LMAT, NAS:ANGO, NAS:CFMS, NAS:SIEN, NAS:IVTY, NAS:MBOT, NAS:HBIO, AMEX:TRXC, NAS:BIOL, NAS:LAKE, AMEX:BVX, NAS:ATRC » details
Traded in other countries:SR3.Germany,
Headquarter Location:USA
Staar Surgical along with its subsidiaries designs, develops, manufactures and sells implantable lenses and delivery systems for the eye. The Company develops, produces, and markets intraocular lenses.

Staar Surgical along with its subsidiaries designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company develops, produces, and markets intraocular lenses. The Company was incorporated in the state of California in 1982. It was reincorporated in Delaware in 1986. The Company along with its subsidiaries designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The lenses are used in corrective or refractive surgery. The Company also makes lenses for use in surgery that treats cataracts. The Company operates as one operating segment, the ophthalmic surgical market. The Company maintains manufacturing and administrative facilities in the United States, Switzerland and Japan. The Company competes with other elective surgical procedures such as laser vision correction or LASIK, for those consumers who are looking for an alternative to eyeglasses or contact lenses to correct their vision.

Ratios

vs
industry
vs
history
PB Ratio 10.28
STAA's PB Ratio is ranked lower than
89% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.56 vs. STAA: 10.28 )
Ranked among companies with meaningful PB Ratio only.
STAA' s PB Ratio Range Over the Past 10 Years
Min: 1.37  Med: 7.59 Max: 17.59
Current: 10.28
1.37
17.59
PS Ratio 4.52
STAA's PS Ratio is ranked lower than
62% of the 180 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.01 vs. STAA: 4.52 )
Ranked among companies with meaningful PS Ratio only.
STAA' s PS Ratio Range Over the Past 10 Years
Min: 0.34  Med: 3.6 Max: 9.91
Current: 4.52
0.34
9.91
Price-to-Free-Cash-Flow 404.24
STAA's Price-to-Free-Cash-Flow is ranked lower than
99.99% of the 73 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.88 vs. STAA: 404.24 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
STAA' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 50.56  Med: 120.58 Max: 4530
Current: 404.24
50.56
4530
Price-to-Operating-Cash-Flow 109.38
STAA's Price-to-Operating-Cash-Flow is ranked lower than
100% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.90 vs. STAA: 109.38 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
STAA' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 45.96  Med: 90.75 Max: 682.86
Current: 109.38
45.96
682.86
EV-to-EBIT -77.87
STAA's EV-to-EBIT is ranked lower than
99.99% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.30 vs. STAA: -77.87 )
Ranked among companies with meaningful EV-to-EBIT only.
STAA' s EV-to-EBIT Range Over the Past 10 Years
Min: -1066  Med: -13.3 Max: 4076.4
Current: -77.87
-1066
4076.4
EV-to-EBITDA -213.92
STAA's EV-to-EBITDA is ranked lower than
99.99% of the 203 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.15 vs. STAA: -213.92 )
Ranked among companies with meaningful EV-to-EBITDA only.
STAA' s EV-to-EBITDA Range Over the Past 10 Years
Min: -2499  Med: -7.6 Max: 1208.1
Current: -213.92
-2499
1208.1
Current Ratio 2.25
STAA's Current Ratio is ranked lower than
52% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.54 vs. STAA: 2.25 )
Ranked among companies with meaningful Current Ratio only.
STAA' s Current Ratio Range Over the Past 10 Years
Min: 0.77  Med: 2.5 Max: 3.77
Current: 2.25
0.77
3.77
Quick Ratio 1.58
STAA's Quick Ratio is ranked higher than
50% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.67 vs. STAA: 1.58 )
Ranked among companies with meaningful Quick Ratio only.
STAA' s Quick Ratio Range Over the Past 10 Years
Min: 0.15  Med: 1.47 Max: 2.37
Current: 1.58
0.15
2.37
Days Inventory 238.82
STAA's Days Inventory is ranked lower than
84% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 124.79 vs. STAA: 238.82 )
Ranked among companies with meaningful Days Inventory only.
STAA' s Days Inventory Range Over the Past 10 Years
Min: 154.29  Med: 206.58 Max: 291.16
Current: 238.82
154.29
291.16
Days Sales Outstanding 68.27
STAA's Days Sales Outstanding is ranked lower than
68% of the 153 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.76 vs. STAA: 68.27 )
Ranked among companies with meaningful Days Sales Outstanding only.
STAA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 41.05  Med: 54.03 Max: 74.19
Current: 68.27
41.05
74.19
Days Payable 117.77
STAA's Days Payable is ranked higher than
84% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 53.53 vs. STAA: 117.77 )
Ranked among companies with meaningful Days Payable only.
STAA' s Days Payable Range Over the Past 10 Years
Min: 58.49  Med: 94.2 Max: 137.15
Current: 117.77
58.49
137.15

Buy Back

vs
industry
vs
history
5-Year Yield-on-Cost % 1.20
STAA's 5-Year Yield-on-Cost % is ranked lower than
67% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.87 vs. STAA: 1.20 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
STAA' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 1.2
3-Year Average Share Buyback Ratio -3.00
STAA's 3-Year Average Share Buyback Ratio is ranked higher than
51% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -3.20 vs. STAA: -3.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
STAA' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -63.7  Med: -5.9 Max: -1.4
Current: -3
-63.7
-1.4

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 18.40
STAA's Price-to-Net-Current-Asset-Value is ranked lower than
82% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.18 vs. STAA: 18.40 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
STAA' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 2.23  Med: 11.96 Max: 80.56
Current: 18.4
2.23
80.56
Price-to-Tangible-Book 10.82
STAA's Price-to-Tangible-Book is ranked lower than
81% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.77 vs. STAA: 10.82 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
STAA' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.94  Med: 7.05 Max: 39.62
Current: 10.82
0.94
39.62
Price-to-Intrinsic-Value-Projected-FCF 57.50
STAA's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
94% of the 82 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.03 vs. STAA: 57.50 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
STAA' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.9  Med: 5.91 Max: 147.8
Current: 57.5
0.9
147.8
Price-to-Median-PS-Value 1.24
STAA's Price-to-Median-PS-Value is ranked lower than
64% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.14 vs. STAA: 1.24 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
STAA' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.12  Med: 0.99 Max: 24.39
Current: 1.24
0.12
24.39
Earnings Yield (Greenblatt) % -1.28
STAA's Earnings Yield (Greenblatt) % is ranked lower than
75% of the 267 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.18 vs. STAA: -1.28 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
STAA' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -1.28  Med: 0.5 Max: 0.9
Current: -1.28
-1.28
0.9
Forward Rate of Return (Yacktman) % -0.68
STAA's Forward Rate of Return (Yacktman) % is ranked lower than
99.99% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.64 vs. STAA: -0.68 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
STAA' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -38.5  Med: -1.3 Max: 35.5
Current: -0.68
-38.5
35.5

More Statistics

Revenue (TTM) (Mil) $83.51
EPS (TTM) $ -0.14
Beta1.90
Short Percentage of Float7.87%
52-Week Range $5.06 - 11.50
Shares Outstanding (Mil)40.93

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 87 96 56
EPS ($) -0.18 -0.11 0.22
EPS without NRI ($) -0.18 -0.11 0.22
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for STAA

Headlines

Articles On GuruFocus.com
STAAR Surgical Announces CE Mark Approval for the EVO+ Visian ICL with Aspheric (EDOF) Optic May 11 2017 
STAAR Surgical to Report First Quarter Results on May 3, 2017 Apr 24 2017 
STAAR Surgical Names Deborah Andrews Interim CFO Apr 05 2017 
Insider Trades of the Week: Facebook, Delta Air Lines May 20 2016 
Weekly CFO Sells Highlight: MHR, DISCA, BCR, STAA, PEGA, IDXX Aug 22 2011 

More From Other Websites
STAAR Surgical Co. breached its 50 day moving average in a Bearish Manner : STAA-US : May 22, 2017 May 22 2017
STAAR Surgical Announces CE Mark Approval for the EVO+ Visian ICL with Aspheric (EDOF) Optic May 11 2017
ETFs with exposure to STAAR Surgical Co. : May 8, 2017 May 08 2017
Edited Transcript of STAA earnings conference call or presentation 3-May-17 8:30pm GMT May 06 2017
STAAR Surgical Co. :STAA-US: Earnings Analysis: Q1, 2017 By the Numbers : May 5, 2017 May 05 2017
Staar Surgical reports 1Q loss May 03 2017
STAAR Surgical Reports First Quarter 2017 Results May 03 2017
Investor Network: STAAR Surgical Company to Host Earnings Call May 03 2017
STAAR Surgical Co. – Value Analysis (NASDAQ:STAA) : April 27, 2017 Apr 27 2017
STAAR Surgical Co. breached its 50 day moving average in a Bullish Manner : STAA-US : April 26, 2017 Apr 26 2017
STAAR Surgical to Report First Quarter Results on May 3, 2017 Apr 24 2017
STAAR Surgical Names Deborah Andrews Interim CFO Apr 05 2017
STAAR Surgical Co. breached its 50 day moving average in a Bullish Manner : STAA-US : March 31, 2017 Mar 31 2017
STAAR Surgical Co. :STAA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Mar 20 2017
STAAR Surgical Co. :STAA-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017 Mar 14 2017
Staar Surgical posts 4Q loss Mar 02 2017
STAAR Surgical Reports Fourth Quarter 2016 Results Mar 02 2017
STAAR Surgical to Report Fourth Quarter Results on March 2, 2017 Feb 16 2017
ETFs with exposure to STAAR Surgical Co. : December 13, 2016 Dec 13 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}